back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-12-14 15:02 Tx date 2020-12-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-2,266,398.3105
-114,055 vol $19.87 each |
190,867 | |
| Filed 2020-12-14 14:59 Tx date 2020-12-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,640,110
+114,055 vol $14.38 each |
304,922 | |
| Filed 2020-12-14 14:58 Tx date 2020-12-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,640,110.90
-114,055 vol $14.38 each |
101,148 | |
| Filed 2020-12-01 16:09 Tx date 2020-11-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-268,207.4226
-13,663 vol $19.63 each |
190,867 | |
| Filed 2020-12-01 16:08 Tx date 2020-11-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$196,473
+13,663 vol $14.38 each |
204,530 | |
| Filed 2020-12-01 16:07 Tx date 2020-11-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-196,473.94
-13,663 vol $14.38 each |
215,203 | |
| Filed 2020-12-01 16:06 Tx date 2020-11-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-425,196.3534
-21,658 vol $19.63 each |
190,867 | |
| Filed 2020-12-01 16:05 Tx date 2020-11-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$311,442
+21,658 vol $14.38 each |
212,525 | |
| Filed 2020-12-01 16:04 Tx date 2020-11-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-311,442.04
-21,658 vol $14.38 each |
228,866 | |
| Filed 2020-12-01 16:02 Tx date 2020-11-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-29,115.4424
-1,483 vol $19.63 each |
190,867 | |
| Filed 2020-12-01 16:01 Tx date 2020-11-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,678
+1,438 vol $14.38 each |
192,350 | |
| Filed 2020-12-01 16:00 Tx date 2020-11-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-21,325.54
-1,483 vol $14.38 each |
250,524 | |
| Filed 2020-09-14 11:21 Tx date 2020-09-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-91,635.39
-5,667 vol $16.17 each |
190,912 | |
| Filed 2020-08-20 16:57 Tx date 2020-08-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-79,831.16
-4,567 vol $17.48 each |
196,579 | |
| Filed 2020-08-20 16:55 Tx date 2020-08-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$178,890
+10,234 vol $17.48 each |
201,146 | |
| Filed 2020-08-20 16:55 Tx date 2020-08-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,234 vol |
44,123 | |
| Filed 2020-03-11 17:21 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-55,332.16
-2,264 vol $24.44 each |
190,912 | |
| Filed 2020-03-11 17:21 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$123,984
+5,073 vol $24.44 each |
193,176 | |
| Filed 2020-03-11 17:20 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-123,984.12
-5,073 vol $24.44 each |
54,357 | |
| Filed 2020-03-11 16:43 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,004 vol |
18,008 | |
| Filed 2020-03-11 16:42 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,004 vol |
9,004 | |
| Filed 2020-03-11 16:41 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+56,858 vol |
252,007 | |
| Filed 2020-03-11 16:40 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+13,506 vol |
59,430 | |
| Filed 2020-02-28 17:04 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-41,002 vol |
0 | |
| Filed 2020-02-28 16:51 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$553,305
+20,911 vol $26.46 each |
138,852 | |
| Filed 2020-02-28 16:51 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,799,018
+105,783 vol $26.46 each |
244,635 | |
| Filed 2020-02-28 16:50 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-20,911 vol |
||
| Filed 2020-02-28 16:50 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-20,911 vol |
20,091 | |
| Filed 2020-02-28 16:48 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-1,495,836.72
-56,532 vol $26.46 each |
188,103 | |
| Filed 2020-02-28 16:47 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-105,783 vol |
||
| Filed 2020-02-28 16:46 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,799,018
+105,783 vol $26.46 each |
||
| Filed 2020-02-28 16:43 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$553,305
+20,911 vol $26.46 each |
||
| Filed 2020-02-28 16:41 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-105,783 vol |
||
| Filed 2020-02-28 16:36 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-20,911 vol |
||
| Filed 2020-02-28 16:36 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-20,911 vol |
||
| Filed 2020-01-07 18:31 Tx date 2020-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-435,605.28
-14,559 vol $29.92 each |
117,941 | |
| Filed 2020-01-07 18:30 Tx date 2020-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,294,937
+43,280 vol $29.92 each |
132,500 | |
| Filed 2020-01-07 18:29 Tx date 2020-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-43,280 vol |
45,924 | |
| Filed 2019-08-26 18:29 Tx date 2019-08-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+30,703 vol |
89,204 | |
| Filed 2019-08-26 18:26 Tx date 2019-08-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$650,142
+30,703 vol $21.18 each |
89,220 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+44,290 vol |
195,149 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+15,221 vol |
58,501 | |
| Filed 2019-01-07 Tx date 2019-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-245,854.17
-13,311 vol $18.47 each |
58,517 | |
| Filed 2019-01-07 Tx date 2019-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$799,381
+43,280 vol $18.47 each |
71,828 | |
| Filed 2019-01-07 Tx date 2019-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-43,280 vol |
43,280 | |
| Filed 2018-01-05 Tx date 2018-01-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-306,089.40
-14,730 vol $20.78 each |
28,548 | |
| Filed 2018-01-05 Tx date 2018-01-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$899,316
+43,278 vol $20.78 each |
43,278 | |
| Filed 2018-01-05 Tx date 2017-01-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-05 Tx date 2018-01-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-43,278 vol |
86,560 | |
| Filed 2017-03-06 Tx date 2017-01-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-06 Tx date 2017-03-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,169,352
+150,859 vol $14.38 each |
150,859 | |
| Filed 2017-01-06 Tx date 2017-01-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+41,002 vol |
41,002 | |
| Filed 2017-01-06 Tx date 2017-01-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-01-06 Tx date 2017-01-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+129,838 vol |
129,838 | |
| Filed 2017-01-06 Tx date 2017-01-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|